Shu-ming He

发表

Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication

Shufeng Zhou, Shu-ming He, Shu-mei Zeng, 2015, Drug design, development and therapy.

Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.

W. Duan, Shufeng Zhou, Tianxin Yang, 2014, Cancer letters.

Effects of herbal products on the metabolism and transport of anticancer agents

Shufeng Zhou, Shu-ming He, Yao-Min Du, 2010, Expert opinion on drug metabolism & toxicology.

[CA 125 expression in cervical and vaginal secretions in women in normal reproductive period].

F. Xing, Shu-ming He, H. Sui, 2010, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells

W. Duan, Shufeng Zhou, Tianxin Yang, 2015, Drug design, development and therapy.

[Effect of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis].

Shu-ming He, Li-hong He, Yan Han, 2005, Zhonghua fu chan ke za zhi.

Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells

Shufeng Zhou, Shu-ming He, Zhi-Wei Zhou, 2015, International journal of molecular sciences.

Identification of molecular targets associated with ethanol toxicity and implications in drug development.

Shufeng Zhou, Shu-ming He, Zhi-Wei Zhou, 2010, Current pharmaceutical design.

Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer

Shufeng Zhou, Dong Wang, Shu-ming He, 2011, Medical science monitor : international medical journal of experimental and clinical research.

Placental drug disposition and its clinical implications.

Shufeng Zhou, Shu-ming He, Naomi Weier, 2008, Current drug metabolism.

ADME properties of herbal medicines in humans: evidence, challenges and strategies.

Shufeng Zhou, E. Chan, Shu-ming He, 2011, Current pharmaceutical design.

Herbal interactions with anticancer drugs: mechanistic and clinical considerations.

Shufeng Zhou, M. Wei, Shu-ming He, 2010, Current medicinal chemistry.

Effects of herbal products on the metabolism and transport of anticancer agents

Shufeng Zhou, Shu-ming He, Yao-Min Du, 2010, Expert opinion on drug metabolism & toxicology.